ATE308523T1 - Ester von 3-(3,4-dihalogenophenyl)-2,6- dioxopiperidine-3-propionsäure als zwischenprodukte - Google Patents

Ester von 3-(3,4-dihalogenophenyl)-2,6- dioxopiperidine-3-propionsäure als zwischenprodukte

Info

Publication number
ATE308523T1
ATE308523T1 AT99973487T AT99973487T ATE308523T1 AT E308523 T1 ATE308523 T1 AT E308523T1 AT 99973487 T AT99973487 T AT 99973487T AT 99973487 T AT99973487 T AT 99973487T AT E308523 T1 ATE308523 T1 AT E308523T1
Authority
AT
Austria
Prior art keywords
dioxopiperidine
propionic acid
esters
dihalogenophenyl
intermediate products
Prior art date
Application number
AT99973487T
Other languages
English (en)
Inventor
Bertrand Castro
Jean-Robert Dormoy
Alain Rabion
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE308523T1 publication Critical patent/ATE308523T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
AT99973487T 1998-12-18 1999-12-01 Ester von 3-(3,4-dihalogenophenyl)-2,6- dioxopiperidine-3-propionsäure als zwischenprodukte ATE308523T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816087A FR2787448B3 (fr) 1998-12-18 1998-12-18 Ester d'alkyle inferieur de l'acide 3-(3,4-dihalogenophenyl) -2,6-dioxopiperidine3-propionique et son mode de preparation
PCT/FR1999/002970 WO2000037445A1 (fr) 1998-12-18 1999-12-01 Esters d'alkyle de l'acide 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionique utiles comme intermediaire

Publications (1)

Publication Number Publication Date
ATE308523T1 true ATE308523T1 (de) 2005-11-15

Family

ID=9534203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99973487T ATE308523T1 (de) 1998-12-18 1999-12-01 Ester von 3-(3,4-dihalogenophenyl)-2,6- dioxopiperidine-3-propionsäure als zwischenprodukte

Country Status (9)

Country Link
US (3) US6469173B1 (de)
EP (1) EP1140842B1 (de)
JP (1) JP2002533327A (de)
AT (1) ATE308523T1 (de)
AU (1) AU1392600A (de)
CA (1) CA2350683A1 (de)
DE (1) DE69928123T2 (de)
FR (1) FR2787448B3 (de)
WO (1) WO2000037445A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787448B3 (fr) * 1998-12-18 2001-01-12 Sanofi Sa Ester d'alkyle inferieur de l'acide 3-(3,4-dihalogenophenyl) -2,6-dioxopiperidine3-propionique et son mode de preparation
WO2017110729A1 (ja) * 2015-12-22 2017-06-29 住友化学株式会社 ベンズオキサゾール化合物の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2745811B1 (fr) 1996-03-07 1998-05-22 Sanofi Sa Glutarimide disubstitue procede pour sa preparation, et son utilisation
JP2000515534A (ja) * 1996-08-05 2000-11-21 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ ３，３―二置換ピペリジンの製造方法
GB9714129D0 (en) 1997-07-04 1997-09-10 Pfizer Ltd Azetidines
FR2787448B3 (fr) * 1998-12-18 2001-01-12 Sanofi Sa Ester d'alkyle inferieur de l'acide 3-(3,4-dihalogenophenyl) -2,6-dioxopiperidine3-propionique et son mode de preparation
US6673595B2 (en) * 2001-08-27 2004-01-06 Biocrystal, Ltd Automated cell management system for growth and manipulation of cultured cells

Also Published As

Publication number Publication date
EP1140842B1 (de) 2005-11-02
US20030032810A1 (en) 2003-02-13
EP1140842A1 (de) 2001-10-10
US20040110796A1 (en) 2004-06-10
US6469173B1 (en) 2002-10-22
FR2787448A1 (fr) 2000-06-23
CA2350683A1 (en) 2000-06-29
AU1392600A (en) 2000-07-12
FR2787448B3 (fr) 2001-01-12
US6946269B2 (en) 2005-09-20
DE69928123T2 (de) 2006-08-03
JP2002533327A (ja) 2002-10-08
DE69928123D1 (de) 2005-12-08
WO2000037445A1 (fr) 2000-06-29
US6686182B2 (en) 2004-02-03

Similar Documents

Publication Publication Date Title
ES2188017T3 (es) Procedimiento de preparacion de gamma butirolactonas hidroxi-sustituidas.
BR9508308A (pt) Derivados de benzoíla e sintese dos mesmos
DE69727162D1 (de) Herstellung von inulinhaltigen Produkten
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
PT1070136E (pt) Estirpe de microorganismo penicillium oxalicum var. armeniaca e a sua aplicacao
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний
ATE308523T1 (de) Ester von 3-(3,4-dihalogenophenyl)-2,6- dioxopiperidine-3-propionsäure als zwischenprodukte
BR0114884A (pt) Compostos calcilìticos
AU6832498A (en) Substituted benzyl oximino compounds
TR200400907T4 (tr) Beta D 5-Tiyoksiloz türevleri, bunları hazırlama yöntemi ve bunların terapötik kullanımları
DE60006125D1 (de) Herstellung von 2-(2-arylmorpholin-2-yl)ethanolderivaten und zwischenprodukte
DE69705849D1 (de) Herstellung von 3,5-lutidin
DE60002486D1 (de) 1,4-dihydropyridin-5-carbonsäureester-derivate und verfahren zu ihrer herstellung
DE69508251D1 (de) Benzoylderivate und ihre herstellung
DE69109953T2 (de) Alfa-fluorocarbonsäurederivate als Zwischenprodukte zur Herstellung von Fungiziden.
ATE208365T1 (de) Aromatische polycyclische derivate des retinoidtyps, verfahren zu ihrer herstellung und ihre verwendung zur herstellung der pharmazeutischen und kosmetischen zusammensetzungen
IL119450A0 (en) Process for preparing optically active carboxylic acids
NO20006527L (no) Forbedret fremgangsmåte for fremstilling av substituerte pyridinkarboksylsyrer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties